Registration - Consultant

Entos Pharmaceuticals / Farid Foroud, Consultant

Registration Information

Client name: Entos Pharmaceuticals
Lobbyist name: Farid Foroud, Consultant
Initial registration start date: 2020-08-10
Registration status: Active
Registration Number: 946285-367219

Associated Communications

Total Number of Communication Reports: 5

Monthly communication reports in the last 6 months: 0

Version 10 of 11 (2023-11-22 to 2024-05-16)

Registration versions:

Version 10 of 11 (2023-11-22 to 2024-05-16)

Lobbying Information

Subject Matters

Economic Development
Government Procurement
Health
Industry
Small Business

Subject Matter Details

Policies or Program

To advocate for Entos' biomanufacturing facility in Edmonton Alberta for development of genetic medicines and vaccines in Canada including Entos' lead DNA vaccine program for COVID-19.

Communication Techniques

Written communication
Oral communication

The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.

Government Institutions

Finance Canada (FIN)
Health Canada (HC)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
Prairies Economic Development Canada (PrairiesCan)
Public Services and Procurement Canada (PSPC)

Client Details

Government funding

End date of the last completed financial year: 2023-05-31

List of Government Funding
Government Institution	Funding Received in Last Financial Year	Funding Expected in Current Financial Year
Government of Alberta	$15,500,000.00	No
National Research Council (NRC)	$10,000,000.00	Yes

Client Contact Information

Address:
Unit 4550, 10230 Jasper Avenue
Edmonton, AB T5J 4P6
Canada

Telephone number: 780-862-7445
Web address: https://www.entospharma.com/

Client representative

John Lewis, Chief Executive Officer

Parent Company Information

Entos Pharmaceuticals is not a subsidiary of any other parent companies.

Coalition Members Information

Entos Pharmaceuticals is not a coalition.

Individual, organization or corporation with a Direct Interest Beneficiary Information

The activities of Entos Pharmaceuticals are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.

Subsidiary Beneficiary Information

Entos Pharmaceuticals does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyist Details

Farid Foroud | No public offices held

Business address:
10137 104 Street NW, Suite 202
Edmonton, AB T5J 0Z9
Canada

Telephone number: 587-338-0010

Consultant Firm and Address

Firm: Global Public Affairs Inc.

Address:
10137 104 Street NW, Suite 202
Edmonton, AB T5J 0Z9
Canada

Telephone number: 587-338-0010

Entos Pharmaceuticals/

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Entos Pharmaceuticals/	2024-05-16	current
Entos Pharmaceuticals/	2020-08-10	2024-05-16

The following names have been used before July 2, 2008

Entos Pharmaceuticals/

Entos Pharmaceuticals

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

Farid Foroud, Global Public Affairs Inc. (Consultant)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-5 of 5

Entos Pharmaceuticals
Consultant: Farid Foroud

Designated Public Office Holders who participated in the communication:
- Anna Bodnar, Policy Advisor | Office of the Minister | Prairies Economic Development Canada (PrairiesCan)
Subject Matter of the communication: Economic Development, Health, Industry
Communication date: 2022-06-10
Posted date: 2022-06-14
Communication number: 367219-534480 View associated registration
Entos Pharmaceuticals
Consultant: Farid Foroud

Designated Public Office Holders who participated in the communication:
- Ekateryna Nova, Regional Advisor, West and North | Innovation, Science and Economic Development Canada (ISED)
- Bianca Hossain, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Health, Industry
Communication date: 2022-05-16
Posted date: 2022-06-14
Communication number: 367219-534481 View associated registration
Entos Pharmaceuticals
Consultant: Farid Foroud

Designated Public Office Holders who participated in the communication:
- Megan Jarosch, Senior Advisor | Prairies Economic Development Canada (PrairiesCan)
Subject Matter of the communication: Health
Communication date: 2022-05-16
Posted date: 2022-05-16
Communication number: 367219-532157 View associated registration
Entos Pharmaceuticals
Consultant: Farid Foroud

Designated Public Office Holders who participated in the communication:
- Morgan Breitkreutz, Director of Operations | Office of the Minister of Tourism and Associate Minister of Finance | House of Commons
- Ekateryna Nova, Regional Advisor | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development
Communication date: 2022-02-25
Posted date: 2022-03-15
Communication number: 367219-525477 View associated registration
Entos Pharmaceuticals
Consultant: Farid Foroud

Designated Public Office Holders who participated in the communication:
- François-Philippe Champagne, Minister of Innovation, Science and Industry | Minister's Office | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health
Communication date: 2021-06-16
Posted date: 2021-06-16
Communication number: 367219-509085 View associated registration

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - Consultant

Entos Pharmaceuticals / Farid Foroud, Consultant

Registration Information

Associated Communications

Version 10 of 11 (2023-11-22 to 2024-05-16)

Version 10 of 11 (2023-11-22 to 2024-05-16)

Subject Matters

Subject Matter Details

Policies or Program

Communication Techniques

Government Institutions

Government funding

Client Contact Information

Client representative

Parent Company Information

Coalition Members Information

Individual, organization or corporation with a Direct Interest Beneficiary Information

Subsidiary Beneficiary Information

Consultant Firm and Address